Taysha Gene Therapies doses patient #2 and provides an update on their clinical trial plans in Canada, US and UK.

So many things about Rett are beyond our control. Accelerating a cure isn’t one of them. Sign up for the Registry now to help drive the development of genetic medicines. #ParentPowered

We are the organization working to cure Rett Syndrome.

You have the power to unlock a world of information, which will entice more Biopharma companies to take on Rett.

Check your RettList today to help us bring #PharmaToTable.

So many things about Rett are beyond our control. Accelerating a cure isn’t one of them. Sign up for the Registry now to help drive the development of genetic medicines. #ParentPowered

We are the organization working to cure Rett Syndrome.

You have the power to unlock a world of information, which will entice more Biopharma companies to take on Rett.

Check your RettList today to help us bring #PharmaToTable.

Donate

Join Us

Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome

On November 14, 2023 Taysha Gene Therapies provided an encouraging update on Patient #1 and #2. Please see links below for clinical updates and timelines for US and UK trials.

Letter to Patient Advocacy Leaders

Taysha Press Release

$40M

Take Action

Taysha Provides Update on Patient #1 and #2